Post-approval studies (Phase 4)Study completedNCT00948766
What this trial is testing
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Who this might be right for
Alzheimer's Disease
Novartis 716